BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 22020319)

  • 21. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway.
    Wang HJ; Cao JP; Yu JK; Zhang LC; Jiang ZJ; Gao DS
    Eur J Pharmacol; 2008 Oct; 595(1-3):7-12. PubMed ID: 18703048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
    Jiang Z; Yu PH
    Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-permeable cAMP analog suppresses 6-hydroxydopamine-induced apoptosis in PC12 cells through the activation of the Akt pathway.
    Fujita H; Ogino T; Kobuchi H; Fujiwara T; Yano H; Akiyama J; Utsumi K; Sasaki J
    Brain Res; 2006 Oct; 1113(1):10-23. PubMed ID: 16945353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
    Chen L; Cheng L; Wei X; Yuan Z; Wu Y; Wang S; Ren Z; Liu X; Liu H
    Neurochem Res; 2017 Apr; 42(4):1141-1150. PubMed ID: 28005221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway.
    Sun S; Li F; Gao X; Zhu Y; Chen J; Zhu X; Yuan H; Gao D
    Neuroscience; 2011 Dec; 199():359-67. PubMed ID: 22020319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphoinositide 3-kinase signalling--which way to target?
    Wymann MP; Zvelebil M; Laffargue M
    Trends Pharmacol Sci; 2003 Jul; 24(7):366-76. PubMed ID: 12871670
    [No Abstract]   [Full Text] [Related]  

  • 28. PI3K/AKT signaling mediated by G protein‑coupled receptors is involved in neurodegenerative Parkinson's disease (Review).
    Nakano N; Matsuda S; Ichimura M; Minami A; Ogino M; Murai T; Kitagishi Y
    Int J Mol Med; 2017 Feb; 39(2):253-260. PubMed ID: 28000847
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.